Key result
Automated R6000 system matches physician CAN diagnosis with ~98% agreement while saving 33 minutes.
Why the study?
The conventional diagnostic process for cardiovascular autonomic neuropathy is often time-consuming and lacks standardization.
Does the automated Cardiovascular Autonomic Nervous Function Multi-Parameter Evaluation System (Model R6000) improve standardization, diagnostic accuracy, and time efficiency in evaluating cardiovascular autonomic neuropathy compared to conventional manual methods in patients with diabetes and healthy adults?
Does the automated Cardiovascular Autonomic Nervous Function Multi-Parameter Evaluation System (Model R6000) improve standardization, diagnostic accuracy, and time efficiency in evaluating cardiovascular autonomic neuropathy compared to conventional manual methods in patients with diabetes and healthy adults?
Answers are grounded in this paper and cite their sources.
This novel automated human-machine interaction system standardizes cardiovascular autonomic reflex testing, achieving near-perfect diagnostic agreement with physicians (kappa = 0.979) while cutting examination and analysis time in half (saving 33 minutes) and requiring only one examiner.
Background and Objectives: The conventional diagnostic process for cardiovascular autonomic neuropathy (CAN) is often time-consuming and lacks standardization. The Cardiovascular Autonomic Nervous Function Multi-Parameter Evaluation System is the first intelligent device designed for CAN diagnosis, featuring wireless wearable modules and human‒computer interaction. This study aims to evaluate the accuracy and eficiency of the novel device. Methods: A two-part, paired-design multicenter study involving a total of 200 subjects (122 with diabetes) from three centers was conducted. Cardiovascular autonomic reflex tests (CARTs) and 5-min heart rate variability (HRV) analyses were performed via the study device. Concurrent manual measurements with physician diagnoses and nonstandardized conventional methods served as controls in Part I and Part II, respectively. Part II showed weak to moderate intermethod correlations with the nonstandardized conventional method (ICCs = 0.193‒0.632). Repeated tests revealed high reproducibility (coefficients of variation = 3%‒20%). The investigational device required only one examiner to perform a standardized assessment and saved 33 minutes compared with manual methods. Conclusions: The proposed system provides eficient and standardized testing with excellent accuracy and reproducibility for CAN assessment. This novel device will facilitate the evaluation of therapeutic efficacy and promote streamlined clinical workflows.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2025) studied Cardiovascular autonomic neuropathy (CAN) in diabetes (n=200). Cardiovascular Autonomic Nervous Function Multi-Parameter Evaluation System (Model R6000) vs. Concurrent manual measurements with physician diagnosis (Part I) and nonstandardized conventional manual methods (Part II) was evaluated on Agreement between the study device and physician diagnosis in diagnosing CAN in Part I (assessed by Cohen's kappa) (Cohen's kappa 0.979 (5-category weighted kappa 0.972, overall agreement 98%), p=< 0.001). The automated R6000 evaluation system achieved 98% diagnostic agreement with physicians for cardiovascular autonomic neuropathy while saving 33 minutes per test.
Synapse has enriched 10 related papers. Consider them for comparative context: